The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $501,145 in first-year total cost, median $250,573.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-A (13)]1
- Special Emphasis Panel[ZRG1 ETTN-P (13)]1
Most frequent institutions
- BIODESY, INC1
- SEVEN BIOSCIENCES, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Next generation GPCR drug discovery1R43MH122078-01A1 | MIZUNO, GRACE | SEVEN BIOSCIENCES, INC., CA | $221,400 | ZRG1 |
| 2019 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes1R43MH119906-01 | MOREE, BENO'MALLEY, MICHELLE ANN | BIODESY, INC, CA | $279,745 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.